Bilberry extract

Quick links to important sections

Bilberry extract

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bilberry extract

Property Description
Active Ingredient Anthocyanosides (Standardized flavonoids)
Form Capsule, tablet, or liquid extract (Oral administration)
Pharmacological Class Angioprotective agent / Antioxidant
Common Use Support for microcirculation and visual function
Origin Natural origin (phytomedicine) from Vaccinium myrtillus L.

Bilberry extract is a natural origin phytomedicine derived exclusively from the ripe fruit of Vaccinium myrtillus L., commonly known as the European blueberry. It is classified as an Angioprotective agent and a potent Antioxidant, designations that describe its function in supporting vascular and cellular integrity. A key feature of this extract is its origin, as the European variety often contains high concentrations of key anthocyanosides that are associated with effects on collagen and blood vessels. Traditional use of the fruit has been utilized for managing minor venous circulatory disturbances and addressing symptoms of capillary fragility in the skin. This demonstrates the product's general purpose is to assist in maintaining the structural health of blood vessels, which is essential for healthy circulation.

Active Components and Standardized Composition

The core active ingredients in the extract are a specific group of flavonoids called anthocyanosides. These compounds are the source of the extract's free radical scavenging and angioprotective properties. The product is manufactured as a standardized extract to ensure a consistent, quantified level of these components; for instance, powdered bilberry extract should contain not less than 36.0% of anthocyanosides. The standardization process ensures that the product provides a reproducible quantity of the key chemical components. Bilberry extract is intended for the oral route of administration and is available as a single product in high-level dosage form(s) including the capsule and tablet.

Regulatory References

  1. United States Pharmacopeia–National Formulary (USP-NF)
  2. Powdered Bilberry Extract

What side effects are possible with Bilberry extract?

Possible side effects and safety information

Regulatory documentation characterizes the adverse reaction profile for Bilberry extract as involving few reported events that are generally mild and transient. No specific frequency classifications (such as common or rare) are universally applied to the documented effects; the emphasis is on the overall low occurrence and severity.


Adverse Reaction Profile and System-Organ Effects

The most commonly noted adverse effects are related to Gastrointestinal disorders and are typically mild, including nausea and abdominal discomfort. Other minor reported effects include flatulence and heartburn. Serious adverse reactions are not consistently documented in regulatory labels for standard therapeutic use. The potential for Hypersensitivity reactions is also acknowledged, related to a formal contraindication.


Safety-Related Restrictions and Data Gaps

Specific safety constraints are defined in regulatory-aligned monographs. Use is contraindicated in individuals with known hypersensitivity to the active substance or plants of the same family. Furthermore, the extract may pose a safety risk related to drug interactions:

Constraint Consequence Documented in Regulatory Sources
Use with Anticoagulants (e.g., Warfarin) Potential for excessive bleeding or bruising (increased action)
Use with Antidiabetics Increased risk of hypoglycemia
Concomitant use with Iron Potential interference with iron absorption

Finally, safety is not established for use in children under 12 years of age or during pregnancy and lactation due to a lack of adequate regulatory data. Safety for high doses or prolonged use is also not definitively established.

Overdose and Emergency Response

The official regulatory profile for Bilberry extract is largely defined by the historical use data documented in governmental sources. Specifically, regulatory monographs, such as those from the European Medicines Agency, explicitly state that no case of overdose has been reported for preparations derived from Vaccinium myrtillus L.

This means that official labeling does not include a specific list of clinical signs, symptoms, or expected physiological outcomes resulting from an acute ingestion that exceeds the normal recommended use. Similarly, no specific severity classification or population-specific considerations regarding overdose are documented. Authoritative health resources further support that the product is considered unlikely to be implicated in acute, serious outcomes such as liver injury.

In the event of any accidental acute ingestion, treatment listed in official documentation is symptomatic and supportive. There is no specific antidote known or described in regulatory information. Urgent medical help or contact with a Poison Control Center is mandated if serious acute systemic symptoms occur, such as experiencing trouble breathing or passing out. Hospital monitoring and supportive care may be required in severe scenarios.

Therapeutic Uses of Bilberry extract

The extract is associated with the traditional management of certain distressing symptoms.

Support for Symptoms of Minor Venous Discomfort

Bilberry extract is commonly used in situations involving certain distressing symptoms, specifically to help ease feelings of heaviness, aching, and tiredness in the legs, which are symptoms related to physical discomfort from minor venous circulatory disturbances. This support helps contribute to improved comfort during periods of heightened symptoms, particularly during phases when symptoms become more noticeable due to prolonged static posture or immobility.

Mitigation of Visual Fatigue and Strain

The extract is applied in addressing symptom clusters that may become intense or disruptive, such as visual strain and temporary difficulty in adapting to dim light. It supports the patient during difficult episodes by easing distress associated with extended visual demands (e.g., long periods of screen use), which helps maintain a sense of stability when symptoms are more noticeable.

Complementary Care for Capillary Fragility

Bilberry extract is relevant for managing symptoms that interfere with daily comfort when associated with fragile capillary walls. This supportive function is applied in scenarios where additional management of discomfort is required, which helps ease the overall symptom burden.


Quick Fact: Relief for Leg Heaviness Bilberry extract is commonly used during phases when symptoms become more noticeable and supportive relief is needed for leg discomfort associated with prolonged static posture.

Eligibility and Restrictions for Use

Population Eligibility Rules for Bilberry Extract

Official regulatory guidelines strictly define the eligible population for Bilberry extract based on age, physiological status, and underlying health conditions, primarily referencing the European Medicines Agency (EMA) traditional use monograph.

Eligibility Status Summary

Population Group Official Regulatory Status
Designated Use Population Adults and the elderly
Absolute Contraindication Patients with known hypersensitivity to the active substance (anthocyanosides) or excipients.
Not Recommended Children and adolescents under 18 years of age; individuals who are pregnant or breastfeeding.

Conditional Use Restrictions

Use of Bilberry extract requires consultation with a doctor or qualified practitioner under specific circumstances. This applies to patients with underlying cardiac insufficiency or renal insufficiency. Consultation is also necessary if patients present with signs of severe venous disease, such as sudden swelling of the legs, ulcers, or thrombophlebitis. The restrictions for those under 18 and for pregnant/lactating individuals are due to a regulatory determination that safety and efficacy have not been established due to insufficient data.

What should I know about interactions with other medicines?

The official interaction profile for Bilberry extract is primarily defined by its documented additive pharmacodynamic effects. Co-administration with Anticoagulant and Antiplatelet Drugs may potentiate their effects, which is associated with an increased risk of bleeding and bruising. Similarly, when combined with Antidiabetes Drugs, the potential for enhanced blood sugar lowering effect may increase the risk of hypoglycemia.

Interactions are also noted with Herbal and Health Supplements that share similar actions, such as those that reduce blood sugar or affect blood clotting (e.g., garlic, Panax ginseng, ginkgo). The potential for these additive effects requires consideration of all concomitant medications and supplements.

A specific pharmacokinetic interaction is documented concerning Cytochrome P450 2E1 (CYP2E1) Substrates, which may alter the rate at which the liver breaks down these co-administered medications via this metabolic pathway. Separately, the efficacy of the specific medicine Erlotinib may be reduced by co-administration, a statement derived from regulatory-aligned data. No formally contraindicated combinations or mandatory dose separation intervals are explicitly cited in official government documents. Due to the documented effects on glucose, caution is advised concerning use prior to scheduled surgery or in patients with a history of diabetes.

Mechanism of Action

Modulation of Capillary Structure via Enzyme Interaction

The mechanism of Bilberry extract centers on its active components, the anthocyanosides, which function as specific enzyme inhibitors, notably targeting Matrix Metalloproteinases (MMPs). By reducing the activity of these enzymes, the extract biochemically prevents the breakdown of collagen and elastin—the core structural proteins of the capillary basement membrane. This targeted action leads to the physicochemical stabilization of microvessel walls, resulting in a reduction in capillary permeability and modulation of microcirculatory fluid dynamics.

Antioxidant Activity and Oxidative Stress Management

The extract’s action includes a complementary dual-action approach to managing cellular stress, alongside the structural mechanism. Anthocyanosides directly act as scavengers, neutralizing Reactive Oxygen Species (ROS) and free radicals before they can interact with endothelial cell membranes. Furthermore, the mechanism involves modulating cellular pathways to upregulate the production of endogenous antioxidant defenses. This mechanism contributes to the stabilization of vascular system integrity against oxidative degradation.

Modulation of Retinal Photopigment Regeneration Kinetics

A distinct biological action occurs in the eye, where the extract facilitates the metabolic process of regenerating rhodopsin—the visual pigment essential for detecting light. This specific modulation of the phototransduction cascade is the physiological basis for the mechanism's influence on the visual response under reduced illumination.

Dosage and Administration Information

The administration of Bilberry extract follows established parameters that define the routes, dosages, and duration of the treatment course. The dry extract, typically found in capsules or tablets, is intended for the oral route of administration.

Dosing and Frequency

There are established dosing schedules for adults and the elderly. The typical single dose of the dry fresh fruit extract ranges from 80 mg to 180 mg, and this is administered as part of a divided use regimen. The maximum total daily dose is specified as 540 mg of the dry extract.

Duration and Administration Rules

The continuous treatment course with the dry extract is generally limited to a maximum duration of four weeks. This time-bound usage pattern is accompanied by the instruction that if the condition persists or worsens after two weeks of use, a qualified healthcare practitioner must be consulted.

Furthermore, the product's use is subject to age-based exclusion: the fresh fruit dry extract is not recommended for individuals under 18 years of age due to an absence of sufficient data in this population. Beyond the standardized solid oral form, the dried Bilberry fruit substance may also be prepared as a decoction for either oral ingestion (as a tea) or for oromucosal rinsing, based on traditional usage patterns.

Recent Clinical Evidence

Bilberry extract: Recent Clinical Evidence

Evidence for Vascular and Microcirculatory Support

Research exploring conditions related to blood vessel health is largely based on documentation of Traditional Use across Europe and older clinical data. These assessments have examined outcomes related to discomfort, such as feelings of leg heaviness and aching, often associated with minor venous circulatory concerns. The extract was evaluated in studies focused on these physical discomforts during short-term observation periods. However, evidence is limited by a lack of recent, rigorous, large-scale controlled trials, meaning the regulatory classification relies heavily on long-standing experience rather than contemporary data. Similarly, research for capillary fragility primarily rests on Traditional Use documentation.

Evidence for Visual Health and Eye Function

The research base includes placebo-controlled trials and systematic reviews, applied in studies examining physiological strain on the eyes. For Visual Strain and Fatigue, short-term Randomized Controlled Trials (RCTs) monitored parameters related to perceived discomfort after prolonged visual tasks. Findings were mixed across the research, and evidence quality varies across studies due to small sample sizes. Research for Function in Dim Light (Night Vision) was evaluated in RCTs using healthy subjects; the most rigorous systematic reviews indicate that these trials did not generally describe noticeable changes, and certainty remains low.

Long-Term Follow-up and Uncertainty

The existing research focuses primarily on short-term outcomes, with follow-up durations limited to weeks or a few months. Long-term effects are not fully established, and the available data does not fully address the implications of continuous, extended use. Data for certain groups remain insufficient, particularly for children or women who are pregnant, as most research results apply only to the populations studied.

Key Studies & References

  1. Bilberry (Vaccinium myrtillus) for improving vision: a systematic review of clinical trials
  2. Efficacy of bioflavonoids in the management of chronic venous insufficiency: a meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Bilberry extract (FAQ)

Q: Is the Bilberry extract available in Europe different from the extract sold in the US?

Regulatory oversight in different regions has different focus areas. Official European assessments acknowledge the extract based on its Traditional Use for minor circulatory issues. Conversely, the United States Pharmacopeia–National Formulary (USP-NF) primarily defines the quality of the extract by requiring a standardized minimum composition of anthocyanoside content.

Q: What should I do if I experience an unexpected reaction after taking Bilberry extract?

Official safety information emphasizes that use is formally contraindicated (not recommended) for individuals with known hypersensitivity. Should an individual experience any unexpected or serious reaction, particularly signs of an allergy like hives or difficulty breathing, seeking immediate medical assistance is described as necessary.

Q: Can people with gastrointestinal issues use Bilberry extract?

Regulatory documents note that mild gastrointestinal discomfort, such as nausea or flatulence, is among the most commonly reported adverse effects in the general population. For individuals with pre-existing gastrointestinal conditions, consultation with a qualified practitioner is often noted as necessary due to this potential for GI effects.

Q: Is Bilberry extract the same as regular blueberries?

No, official sources specify that the extract is derived from the European bilberry (Vaccinium myrtillus L.), which is botanically distinct from the common cultivated American blueberry. The European variety is recognized for its typically higher concentration of the active components, the anthocyanosides.

Q: Does Bilberry extract interact with over-the-counter pain relievers?

Official documentation notes that the extract may potentiate, or strengthen the effect of, antiplatelet drugs and anticoagulants. This combined action could increase the risk of bruising or bleeding. Official documents recommend discussing all concomitant medications, including non-prescription pain relievers, with a healthcare professional.

Q: What ingredients should I look for on the label of a Bilberry extract product?

Official quality standards require that the label identifies the product as a standardized extract from Vaccinium myrtillus L. This standardization ensures the product specifies the quantified amount of the active components, which are the anthocyanosides.

Q: Are there any known food or drink interactions with Bilberry extract?

A specific interaction is documented in safety information concerning the mineral Iron. Concomitant use with iron supplements may potentially interfere with the absorption of iron. No other common food or drink interactions are formally cited in the regulatory documents provided.

Q: Can individuals with high blood pressure use Bilberry extract?

The official eligibility criteria include conditional use restrictions for individuals with underlying health issues. Official eligibility criteria indicate that patients with conditions such as cardiac insufficiency or severe venous disease require consultation with a healthcare practitioner before use.

Q: How does the quality of the raw material affect the Bilberry extract product?

Regulatory requirements for quality control mandate that the product be a standardized extract. This process is designed to ensure a consistent, quantified amount of active components (anthocyanosides) is present in the final product, regardless of variations in the initial raw material.

Q: Is it true that heat processing can affect the properties of Bilberry extract?

Regulatory storage instructions require the product to be stored away from excessive heat and protected from light and moisture. This is intended to maintain the quality and potency of the extract, as the active components can be negatively affected by high temperatures.

Q: Can Bilberry extract be taken alongside vitamins?

Official documentation cites a potential interaction with the mineral Iron, where concomitant use is documented as potentially interfering with iron absorption. No other general vitamin interactions are formally cited in the regulatory documents provided.

Q: Is there a difference in potency between extracts from fresh and dried Bilberries?

Official regulatory guidelines specify dosage for the dry fresh fruit extract in solid oral forms. Regardless of whether fresh or dried fruit was used to prepare the initial raw material, quality standards focus on the final product having a minimum, standardized concentration of the active component (anthocyanosides).

Q: Why is Bilberry sometimes confused with other similar-looking berries?

Official documentation confirms that the extract is derived only from Vaccinium myrtillus L., the European bilberry. This species is often confused with the common cultivated American blueberry or other related Vaccinium species which may possess different chemical profiles and lack the same regulatory status.

Q: Does Bilberry extract contain any known allergens besides the berry itself?

Use is formally contraindicated (not recommended) for individuals with known hypersensitivity to the active substance (anthocyanosides). This contraindication also extends to any of the excipients, which are the non-active ingredients used in the product formulation.

How should Bilberry extract be stored and disposed of?

Official Storage and Disposal Requirements

Official regulatory guidelines define specific conditions necessary to maintain the quality and potency of Bilberry extract.

Storage Conditions

Requirement Official Instruction
Temperature Store at controlled room temperature, away from excessive heat.
Protection Preserve in well-closed containers, protected from light and moisture.
Handling Store in a cool, dry area and avoid generating dust during cleanup.

These constraints ensure the product maintains its stability until the labeled expiration date. It is mandated that the product remain in its original, sealed container.

Disposal Requirements

Unused or expired Bilberry extract must be disposed of according to all applicable federal, state, and local regulations. To prevent environmental contamination, it is strictly required that the product and any contaminated material not be discharged into drains, sewers, or watercourses.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Bilberry extract found in:

A-Z Index: